Literature DB >> 16894143

Type 1, type 1.5, and type 2 diabetes: NOD the diabetes we thought it was.

Marc Y Donath1, Jan A Ehses.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16894143      PMCID： PMC1567858          DOI： 10.1073/pnas.0605480103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  24 in total

1.  Nonobese diabetic mice express aspects of both type 1 and type 2 diabetes.

Authors:  Rodolfo José Chaparro; Yves Konigshofer; Georg F Beilhack; Judith A Shizuru; Hugh O McDevitt; Yueh-Hsiu Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-08       Impact factor: 11.205

2.  Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes.

Authors:  D Ross Laybutt; Mariela Glandt; Gang Xu; Yu Bai Ahn; Nitin Trivedi; Susan Bonner-Weir; Gordon C Weir
Journal:  J Biol Chem       Date:  2002-11-15       Impact factor: 5.157

Review 3.  The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes.

Authors:  T J Wilkin
Journal:  Diabetologia       Date:  2001-07       Impact factor: 10.122

4.  The Swedish childhood diabetes study--results from a nine year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders.

Authors:  G Dahlquist; L Blom; T Tuvemo; L Nyström; A Sandström; S Wall
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

5.  Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes.

Authors:  M Kibirige; B Metcalf; R Renuka; T J Wilkin
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

6.  Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes.

Authors:  Ingrid M Libman; Massimo Pietropaolo; Silva A Arslanian; Ronald E LaPorte; Dorothy J Becker
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

Review 7.  Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes.

Authors:  Marc Y Donath; Joachim Størling; Kathrin Maedler; Thomas Mandrup-Poulsen
Journal:  J Mol Med (Berl)       Date:  2003-07-18       Impact factor: 4.599

Review 8.  Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications.

Authors:  M Y Donath; P A Halban
Journal:  Diabetologia       Date:  2004-02-07       Impact factor: 10.122

9.  Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region.

Authors:  E Tuomilehto-Wolf; J Tuomilehto; G A Hitman; A Nissinen; J Stengård; J Pekkanen; P Kivinen; E Kaarsalo; M J Karvonen
Journal:  BMJ       Date:  1993-07-17

10.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

Authors:  Alexandra E Butler; Juliette Janson; Susan Bonner-Weir; Robert Ritzel; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461
View more
  9 in total

1.  A high incidence of type 1 diabetes and an alarming increase in the incidence of type 2 diabetes among young adults in Finland between 1992 and 1996.

Authors:  N Lammi; O Taskinen; E Moltchanova; I-L Notkola; J G Eriksson; J Tuomilehto; M Karvonen
Journal:  Diabetologia       Date:  2007-05-11       Impact factor: 10.122

Review 2.  Type 2 diabetes as an inflammatory disease.

Authors:  Marc Y Donath; Steven E Shoelson
Journal:  Nat Rev Immunol       Date:  2011-01-14       Impact factor: 53.106

3.  Obesity, autoimmunity, and double diabetes in youth.

Authors:  Paolo Pozzilli; Chiara Guglielmi; Sonia Caprio; Raffaella Buzzetti
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

4.  Biochemical analysis of Cassia fistula aqueous extract and phytochemically synthesized gold nanoparticles as hypoglycemic treatment for diabetes mellitus.

Authors:  P Daisy; K Saipriya
Journal:  Int J Nanomedicine       Date:  2012-03-07

5.  Effect of active fraction isolated from the leaf extract of Dregea volubilis [Linn.] Benth. on plasma glucose concentration and lipid profile in streptozotocin-induced diabetic rats.

Authors:  Venkatesan Natarajan; Anton Smith Arul Gnana Dhas
Journal:  Springerplus       Date:  2013-08-21

6.  Clinical and Metabolic Characteristics among Mexican Children with Different Types of Diabetes Mellitus.

Authors:  María Lola Evia-Viscarra; Rodolfo Guardado-Mendoza; Edel Rafael Rodea-Montero
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

7.  Design and evaluation of chalconeimine derivatives as α-amylase inhibitors.

Authors:  Prithivirajan Balu; Jebastin Sonia Jas; Marimuthu Govindaraj
Journal:  Bioinformation       Date:  2019-07-31

Review 8.  Can the management of depression in type 2 diabetes be democratized?

Authors:  Gumpeny R Sridhar
Journal:  World J Diabetes       Date:  2022-03-15

9.  Association of hypoxia inducible factor-1 alpha gene polymorphism with both type 1 and type 2 diabetes in a Caucasian (Hungarian) sample.

Authors:  Geza Nagy; Reka Kovacs-Nagy; Eva Kereszturi; Aniko Somogyi; Anna Szekely; Nora Nemeth; Nora Hosszufalusi; Pal Panczel; Zsolt Ronai; Maria Sasvari-Szekely
Journal:  BMC Med Genet       Date:  2009-08-19       Impact factor: 2.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.